Ziting Li
About
In The Last Decade
Ziting Li
37 papers receiving 513 citations
Peers
Comparison fields: 5 of 88
- Molecular Biology 150
- Obstetrics and Gynecology 143
- Reproductive Medicine 109
- Surgery 77
- Epidemiology 73
Countries citing papers authored by Ziting Li
This map shows the geographic impact of Ziting Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ziting Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ziting Li more than expected).
Fields of papers citing papers by Ziting Li
This network shows the impact of papers produced by Ziting Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ziting Li. The network helps show where Ziting Li may publish in the future.
Co-authorship network of co-authors of Ziting Li
This figure shows the co-authorship network connecting the top 25 collaborators of Ziting Li. A scholar is included among the top collaborators of Ziting Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ziting Li. Ziting Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 4 | |
| 4 | 1 | |
| 5 | 65 | |
| 6 | 9 | |
| 7 | 20 | |
| 8 | 21 | |
| 9 | 20 | |
| 10 | 30 | |
| 11 | 2 | |
| 12 | 4 | |
| 13 | 23 | |
| 14 | 73 | |
| 15 | 13 | |
| 16 | Clinical analysis of cervical intraepithelial neoplasia and microinvasive carcinoma managed by general electrosurgical conization | 1 |
| 17 | [A multicenter randomized clinical trial of weekly paclitaxel and carboplatin vs three weeks paclitaxel and carboplatin as first line chemotherapy in epithelial ovarian cancer]. | 5 |
| 18 | 14 | |
| 19 | 32 | |
| 20 | The prognosis of patients with stage Ib-IIb node-negative cervical carcinoma | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.